ONWARD Announces First-in-Human Use of ARC-IM™ Lead to Restore Movement and Function after Spinal Cord Injury
New lead is purpose-designed to optimize the delivery of ONWARD ARC Therapy™EINDHOVEN, the Netherlands, May 15, 2023 -- ONWARD Medical N.V. , the medical technology company creating... | May 15, 2023